A detailed history of Greatmark Investment Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Greatmark Investment Partners, Inc. holds 4,399 shares of ABT stock, worth $523,261. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,399
Previous 4,399 -0.0%
Holding current value
$523,261
Previous $457,000 9.63%
% of portfolio
0.07%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $1,533 - $1,693
-14 Reduced 0.32%
4,399 $499,000
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $360 - $441
-4 Reduced 0.09%
4,413 $485,000
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $38,212 - $45,848
-400 Reduced 8.3%
4,417 $427,000
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $10,078 - $11,229
100 Added 2.12%
4,817 $525,000
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $4,547 - $5,265
-47 Reduced 0.99%
4,717 $456,000
Q2 2022

Jul 28, 2022

BUY
$102.07 - $123.37 $17,556 - $21,219
172 Added 3.75%
4,764 $518,000
Q2 2021

Aug 23, 2021

SELL
$105.79 - $124.53 $7,934 - $9,339
-75 Reduced 1.61%
4,592 $532,000
Q3 2019

Oct 30, 2019

BUY
$81.84 - $88.74 $20,460 - $22,185
250 Added 5.66%
4,667 $390,000
Q4 2018

Feb 01, 2019

SELL
$65.56 - $74.27 $47,531 - $53,845
-725 Reduced 14.1%
4,417 $319,000
Q3 2018

Oct 31, 2018

SELL
$60.81 - $73.36 $30,405 - $36,680
-500 Reduced 8.86%
5,142 $377,000
Q4 2017

Feb 01, 2018

SELL
$53.68 - $57.47 $16,104 - $17,241
-300 Reduced 5.05%
5,642 $322,000
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $285,572 - $318,728
5,942
5,942 $317,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Greatmark Investment Partners, Inc. Portfolio

Follow Greatmark Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.